Loading…
STAAR Surgical Company is projected to rise to $36.20 by 2027, a +15% move from its current price of $31.39. STAA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $30.50 | $31.39 | $32.30 | 0.00% |
| May 30 | $30.14 | $31.39 | $32.68 | -0.01% |
| May 31 | $29.87 | $31.39 | $32.98 | -0.01% |
| Jun 1 | $29.64 | $31.38 | $33.23 | -0.02% |
| Jun 2 | $29.44 | $31.38 | $33.45 | -0.02% |
| Jun 3 | $29.26 | $31.38 | $33.66 | -0.03% |
| Jun 4 | $29.09 | $31.38 | $33.85 | -0.03% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $29.09 | $31.38 | $33.85 | -0.03% |
| Week 2 | $28.19 | $31.37 | $34.91 | -0.07% |
| Week 3 | $27.51 | $31.36 | $35.75 | -0.10% |
| Week 4 | $26.95 | $31.35 | $36.47 | -0.14% |
| Week 5 | $26.46 | $31.34 | $37.11 | -0.17% |
| Week 6 | $26.03 | $31.33 | $37.70 | -0.20% |
| Week 7 | $25.63 | $31.32 | $38.26 | -0.24% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
STAAR Surgical Company designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The implantable collamer lens product family (ICLs) comprises EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists.
STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
STAAR Surgical Company is a healthcare stock trading under the symbol STAA. It is currently priced at $32.47 per share, and its market capitalization is $1.62B. The company is ranked 2167 in market capitalization terms.
The current price sits within a 30-day range of $27.19 to $38.78, and the price has technical support at $24.43 with resistance at $33.05. The SMA50 is $24.51 and the SMA200 is $24.23, indicating the price is above both moving averages. The near-term outlook is reflected in a bullish technical setup and a 30-day range that shows considerable movement.
A major floor 48.7% below — a decisive break under it would weaken the trend.
The nearest floor, 21.6% below — buyers have tended to step in here.
The nearest ceiling, 6.2% above — a clean break opens room to run.
A major ceiling 22.7% above — clearing it would confirm fresh momentum.
Key STAA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of STAA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $32.61 | Sell | $32.25 | Sell |
| MA 10 | $32.14 | Sell | $31.64 | Sell |
| MA 20 | $29.65 | Buy | $30.00 | Buy |
| MA 50 | $25.07 | Buy | $26.52 | Buy |
| MA 100 | $22.16 | Buy | $24.46 | Buy |
| MA 200 | $24.28 | Buy | $23.73 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 62.91 | Neutral |
| Stoch RSI (14) | 7.99 | Buy |
| CCI (20) | 46.10 | Neutral |
| Williams %R (14) | -29.32 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | 17.61 | Buy |
| Bollinger %B (20,2) | 0.66 | Neutral |
| Stochastic %K (14) | 70.68 | Neutral |
| TRIX (15) | 1.22 | Buy |
| Awesome (5,34) | 4.68 | Buy |
| Ultimate (7,14,28) | 53.08 | Neutral |
| Momentum (10) | 3.21 | Buy |
| Aroon Osc (25) | 92.00 | Buy |
| Hull MA (9) | 32.67 | Sell |
| ADX (14) | 42.02 | Buy |
| ATR (14) | 0.72 | Info |
The 30-day technical picture shows bullish momentum with RSI(14) at 80, indicating strong buying pressure. The price currently sits above key moving averages, with SMA50 at $24.51 and SMA200 at $24.23, reinforcing a positive near-term tilt. Support is identified at $24.43 and resistance at $33.05, while the 30-day range spans $27.19 to $38.78, highlighting notable volatility in the period.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $16.10 | $31.39 | $43.12 | 0% | Neutral | |
| $28.58 | $36.20 | $48.66 | +15% | Neutral | |
| $32.01 | $41.72 | $58.20 | +33% | Bullish | |
| $35.27 | $47.09 | $67.63 | +50% | Bullish | |
| $45.29 | $61.77 | $90.95 | +97% | Bullish | |
| $51.72 | $71.91 | $108.21 | +129% | Bullish | |
| $52.26 | $73.99 | $113.53 | +136% | Bullish | |
| $56.59 | $81.51 | $127.29 | +160% | Bullish | |
| $58.96 | $86.31 | $137.00 | +175% | Bullish | |
| $62.45 | $92.86 | $149.64 | +196% | Bullish | |
| $90.42 | $144.36 | $247.84 | +360% | Bullish | |
| $192.51 | $347.64 | $654.53 | +10.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $16.10 | $31.39 | $36.70 | +0.00% |
| June 2026 | $25.95 | $30.50 | $36.73 | -2.83% |
| July 2026 | $26.35 | $31.25 | $38.17 | +2.45% |
| August 2026 | $26.63 | $31.80 | $39.26 | +1.75% |
| September 2026 | $26.17 | $31.43 | $39.15 | -1.14% |
| October 2026 | $26.62 | $32.15 | $40.36 | +2.26% |
| November 2026 | $27.77 | $33.69 | $42.59 | +4.79% |
| December 2026 | $27.81 | $33.88 | $43.12 | +0.59% |
Click any year to see its month-by-month STAA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, STAA is projected to trade between $16.10 and $43.12, averaging $31.39 — a potential gain of 0% from today's $31.39. Price action looks broadly range-bound.
STAAR Surgical Company's 2027 outlook centres on $36.20, within a $28.58 to $48.66 range. That is up +15% on the projected 2026 average. That marks a +15% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, STAA could reach as high as $58.20, with a base case around $41.72 and support toward $32.01 — roughly +33% from $31.39. Momentum favours further upside here.
Expect STAA to range from $35.27 to $67.63 through 2029. The $47.09 average target implies a +50% move from current prices. That is up +13% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The STAA price prediction for 2030 points to an average of $61.77 (low $45.29, high $90.95) — a potential gain of +97% on today's $31.39. Momentum favours further upside here.
In 2031, STAA is projected to trade between $51.72 and $108.21, averaging $71.91 — a potential gain of +129% from today's $31.39. That is up +16% on the projected 2030 average. Buyers look set to stay in control over this stretch.
STAAR Surgical Company's 2032 outlook centres on $73.99, within a $52.26 to $113.53 range. That is up +3% on the projected 2031 average. That marks a +136% change versus current levels. Momentum favours further upside here.
By 2033, STAA could reach as high as $127.29, with a base case around $81.51 and support toward $56.59 — roughly +160% from $31.39. Buyers look set to stay in control over this stretch.
Expect STAA to range from $58.96 to $137.00 through 2034. The $86.31 average target implies a +175% move from current prices. That is up +6% on the projected 2033 average. Momentum favours further upside here.
The STAA price prediction for 2035 points to an average of $92.86 (low $62.45, high $149.64) — a potential gain of +196% on today's $31.39. Buyers look set to stay in control over this stretch.
In 2040, STAA is projected to trade between $90.42 and $247.84, averaging $144.36 — a potential gain of +360% from today's $31.39. That is up +55% on the projected 2035 average. Momentum favours further upside here.
STAAR Surgical Company's 2050 outlook centres on $347.64, within a $192.51 to $654.53 range. That is up +141% on the projected 2040 average. That marks a +10.1x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in STAA today (≈ 31.857279 STAA) could be worth
$11,074.72
+$10,074.72 (+1007%) by 2050 · US Dollar
Based on the average projected STAA price of $347.64 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in STAAwould be worth at today's price.
$1,000 invested in STAA on May 27, 2025 (≈ 52.854122 STAA) would be worth
$1,659.09
+$659.09 (+65.9%) today · 1.66× · US Dollar
Based on a STAA entry price of $18.92 vs. today's $31.39.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $33.05 | $949.77 | -5.0% |
| 1 month ago | $26.68 | $1,176.54 | +17.7% |
| 3 months ago | $20.32 | $1,544.78 | +54.5% |
| 6 months ago | $26.54 | $1,182.74 | +18.3% |
| 1 year ago | $18.92 | $1,659.09 | +65.9% |
| All time (5.0y) ago | $143.95 | $218.06 | -78.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our STAA forecast.
Our base-case forecast reaches $63.00 around 2031.
Implied market cap at $63.00: $3.14B
Looking out over the multi-year horizon, the forecast shows rising averages and bullish sentiment after 2026. For 2026 the average is $32.47 with ROI 0 and neutral sentiment. In 2027 the average is $37.98 with ROI 17 and neutral sentiment, and in 2028 the average is $44.24 with ROI 36.3 and bullish sentiment.
In 2029 the average is $49.98 with ROI 53.9 and bullish sentiment, followed by 2030 at $65.50 with ROI 101.7 and bullish sentiment. The trajectory continues with 2031 at $76.19 (ROI 134.7), 2032 at $78.28 (ROI 141.1), 2033 at $87.33 (ROI 168.9), 2034 at $92.94 (ROI 186.3), and 2035 at $99.43 (ROI 206.2), all with bullish sentiment. By 2040 the average rises to $156.85 (ROI 383.1) and by 2050 the average reaches $374.55 (ROI 1053.5), with bullish sentiment throughout these later years.
These figures are estimates, not guarantees, and actual results may vary.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $65.50 with a min of $48.53 and a max of $95.29, and a forecasted ROI of 101.7% with bullish sentiment.
The forecast shows a bullish sentiment from 2028 onward, with rising averages and positive ROI reaching 101.7% in 2030 and higher in later years (e.g., 134.7% in 2031, 383.1% by 2040, 1053.5% by 2050). Near-term years include neutral sentiment, and 2026 carries ROI of 0%. These are estimates and not guarantees.
Yes. The 2030 max is $95.29, but the forecast shows higher later years: 2031 max $113.17, 2032 max $118.45, and 2033 max $134.38, indicating a path above $100 in later years.
Current price is $32.47 and market capitalization is $1.62B.
The 30-day price range is $27.19 to $38.78.
STAAR Surgical Company Community Discussion
0Share your STAAR Surgical Company price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.